Bone Surgery News Today

GOSSELIES, Belgium, November 08, 2023--Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, announces significant progression for BIOCERA-VET® line in the third quarter of 2023.

TheraVet reports its 2023 half-year results and provides an update on the development of its activities Sales increased by 29% compared to...

Sales increased by 29% compared to first half 2022Number of BIOCERA-VET units distributed1 increased by 31% compared to the first half of 2022, taking into account the successful introduction of BIOCERA-VET 3*1ccAcceleration of sales growth over the summer months of 2023 with more than 250% increase in BIOCERA-VET u...

THURSDAY, April 20, 2023 (HealthDay News) -- Surgery may help you manage pain and other symptoms if you have certain types of arthritis or your arthritis is severe.

Commercial launch of BIOCERA-VET® Bone Surgery Ready-to-Use, BIOCERA-VET® Granules, BIOCERA-VET® Smartgraft and BIOCERA-VET® Osteosarcoma Ready-To-Use in Belgium, France, Netherlands, United Kingdom and IrelandCommercial launch of the BIOCERA-VET line also in SpainBrand-new webshop now operationalGOSSELIES, Wallonia...

Distribution agreement for the new BIOCERA-VET® product line including Bone Surgery - Ready to Use, Osteosarcoma Ready to Use, Granules & Smartgraft - in United Kingdom and IrelandKey marketing and sales support for the upcoming commercial launch of these products in United Kingdom and IrelandGOSSELIES, Wallonia, Be...

Positive safety and efficacy results for BIOCERA-VET® (arthrodesis and canine osteosarcoma) and VISCO-VET® (canine osteoarthritis)Initiation of the pivotal European multicentric clinical study evaluating VISCO-VET® in canine osteoarthritisCommercialization of BIOCERA-VET® Bone Surgery and BIOCERA-VET® Osteosarcoma i...

Positive BIOCERA-VET arthrodesis data will be presented in collaboration with Dr. Guillaume Ragetly (ECVS, ACVS, PhD; France) at the US Veterinary Orthopedic Society The annual conference

04.02.2022 - Regulatory News: TheraVet (Paris:ALVET) (Brussels:ALVET) (ISIN: BE0974387194 - ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, announces today the presentation in collaboration with Dr. Guillaume Ragetly ...

Working still, the growth tines 50— working still, the growth lines. so the _ working still, the growth lines. so the way- working still, the growth lines. so the way we - working still, the growth lines. so the way we dol working still, the growth. lines. so the way we do the surgery— lines. so the way we do the surgery is— lines. so the way we do the surgery is we _ lines. so the way we do the surgery is we make - lines. so the way we do the surgery is we make a - lines. so the way we do...